ZEISS has completed the acquisition of D.O.R.C. (Dutch Ophthalmic Research Center) that includes the EVA NEXUS platform, one of the ophthalmology market’s most advanced dual-function systems. As a result of the deal, ZEISS expects to enhance its Retina Surgery Workflow.
On 4 April 2024, ZEISS confirmed it had purchased D.O.R.C. from the French investment firm Eurazeo SE, following regulatory clearances.
“With D.O.R.C., we have an incredible opportunity to serve ophthalmologists around the world with more complete workflows and solutions than ever before,” said Mr Euan Thomson, president of ophthalmology and head of the Digital Business Unit for ZEISS Medical Technology.
“We’ve set our sights high to become the top player in the world for ophthalmology by leveraging our workflow solutions, enhancing our portfolio offerings and market position in the anterior surgery segment, and by significantly expanding our presence in the posterior surgery segment.”
With D.O.R.C. considered a leader in retina surgical devices and consumables, ZEISS expects to bring a portfolio of market-leading technologies to ophthalmologists, including an expanded digitally-connected Retina Surgery Workflow from ZEISS.
The companies’ portfolios are complementary, exemplified through the EVA NEXUS platform from D.O.R.C. featuring alongside ZEISS’s range of visualisation, diagnostic and therapeutic devices, and surgical instruments and consumables, all connected to a digital ecosystem.
EVA NEXUS is at the core of a D.O.R.C.’s portfolio, comprising a full range of accessories, instruments and liquids for vitreo-retinal and combined cataract procedures.
With the completion of this acquisition, eyecare professionals can expect to benefit from an extensive and unique combination of digitally connected devices and workflow solutions, from clinical pre-operative needs to the surgical operating room, ZEISS stated.
“Together we are stronger. With four decades behind our amazing business and surgeon-inspired innovation, we look forward to writing the next chapter of our success story together with ZEISS Medical Technology,” said Mr Pierre Billardon, CEO of D.O.R.C.
“By joining forces, we can extend our reach, scale our efforts, and accelerate ophthalmic surgery advancements for more surgeons faster than before. I am filled with a great sense of pride and gratitude for every D.O.R.C. team member. Together, we have achieved so much to arrive at this pivotal moment in our journey. And together with ZEISS, we have so much more to accomplish in our bright future ahead to help patients see again.”
More reading
How ZEISS has reimagined the equipment service experience
Key insights from ZEISS cataract roadshow event in Brisbane
ZEISS forms Myopia Advisory Board to advise on innovations
